- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations Investing
- Private Equity
- Real Estate
- Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Insurance Coverage and Recovery
- Intellectual Property, Patent, Trademark and Copyright Litigation
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Franchise and Hospitality
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- COVID-19 Vaccine Rollout
- Coronavirus
- Crisis Practice
- Focus on Women's Health
- The New Administration: Enforcement and Legislative Impact
- Careers
- News & Insights
- About
- Languages
In the News
febrero 21, 2021
/news-and-insights/jules-quinn-comments-on-employers-mandatory-covid-19-vaccine-policies?locale=es
In the News
febrero 12, 2021
/news-and-insights/rich-fields-explains-why-blackrock-expects-a-growth-in-invested-companies-becoming-more-attentive-to-climate-issues?locale=es
In the News
febrero 4, 2021
/news-and-insights/lawcom-profiles-robert-benson-in-its-how-i-made-partner-feature?locale=es
Noticias
Información
COVID-19 Vaccine Updates
marzo 8, 2021
UK Government considers allowing businesses to demand proof of COVID-19 vaccinations or negative test results
Thought Leadership
Client Alert
marzo 8, 2021
What Happened to My Interest Rate? Fed Intensifies Scrutiny of Lenders' SOFR Transition Efforts
COVID-19 Vaccine Updates
marzo 4, 2021
EU Blocks Export of COVID-19 Vaccine Doses to Australia
Noticias
Media Contacts
Micheline S. Tang
Director of Communications
+1 212 556 2301
Antony Collins
Public Relations Manager
+ 44 207 551 2153
Luis Mocete
Public Relations Manager
+1 212 827 4008
Jessie Seyfer
Public Relations Manager
+1 415 318 1223
King & Spalding Preferences Center
Register and SubscribeChina Subsidy Exchange
Read moreCOVID-19 Vaccine Updates
Read moreEnergy Law Exchange
Read MoreK&S Perspectives Podcast Series
Read MoreContacts
Micheline S. Tang
Director of Communications
+1 212 556 2301
Antony Collins
Public Relations Manager
+ 44 207 551 2153
Luis Mocete
Public Relations Manager
+1 212 827 4008
Jessie Seyfer
Public Relations Manager
+1 415 318 1223